3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Wilms Tumor
1
Testicular Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Cyclophosphamide
49
fludarabine phosphate
37
Peripheral Blood Stem Cell Transplantation
32
Cyclosporine
30
Mycophenolic Acid
29
Busulfan
27
Whole-Body Irradiation
25
Radiotherapy
24
Antilymphocyte Serum
24
Filgrastim
23
Melphalan
18
Tacrolimus
16
Methylprednisolone
15
Cord Blood Stem Cell Transplantation
15
Methotrexate
14
Etoposide
12
Thiotepa
8
sargramostim
6
Cytarabine
6
Rituximab
5
fludarabine
4
aldesleukin
4
Therapeutics
4
Sirolimus
4
Carmustine
4
Biopsy
4
thymoglobulin
3
Polymerase Chain Reaction
3
Paclitaxel
3
Itraconazole
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Lithium Carbonate
×
Sarcoma
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts